brivaracetam

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 357336-20-0

Where It Comes From

24 FDA-registered drug labelers
Alivus Life Sciences Limited
Apotex Corp.
Ascend Laboratories, LLC
Aurobindo Pharma Limited
Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd.
Florida Pharmaceutical Products, LLC
Hainan Poly Pharm. Co., Ltd.
Honour Lab Limited
Lee Pharma Limited
Lupin Pharmaceuticals, Inc.
Maithri Laboratories Private Limited
Micro Labs Limited
MSN Life Sciences Private Limited
Novadoz Pharmaceuticals LLC
PAI Holdings, LLC dba PAI Pharma
PURE AND CURE HEALTHCARE PRIVATE LIMITED
SolarisPharmaCorporation
UCB Farchim S.A.
UCB Pharma S.A.
UCB, Inc.
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
Zhejiang Poly Pharm. Co., Ltd.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • brivaracetam
  • Briviact
  • Brivaracetam Oral Solution
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS357336-20-0
PubChem CID9837243
DTXSIDDTXSID00905081
FormulaC11H20N2O2
Mol. Weight212.29 g/mol
SMILESCCCC1CC(=O)N(C1)C(CC)C(=O)N

Data Sources

98372432026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/brivaracetam/cids/JSON

Archive: data/sources/pubchem_name/brivaracetam.json

CAS 357336-20-02026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json